Author:
Xu Hanli,Kang Yulin,Liang Tingming,Lu Sifen,Xia Xiaolin,Lu Zuhong,Hu Lingming,Guo Li,Zhang Lishu,Huang Jiaqiang,Ye Lin,Jiang Peiye,Liu Yi,Xinyi Li,Zhai Jin,Wang Zi,Liu Yangyang
Abstract
Abstract
Background
Drug addiction is a serious problem worldwide and is influenced by genetic factors. The present study aimed to investigate the association between genetics and drug addiction among Han Chinese.
Methods
A total of 1000 Chinese users of illicit drugs and 9693 healthy controls were enrolled and underwent single nucleotide polymorphism (SNP)-based and haplotype-based association analyses via whole-genome genotyping.
Results
Both single-SNP and haplotype tests revealed associations between illicit drug use and several immune-related genes in the major histocompatibility complex (MHC) region (SNP association: log10BF = 15.135, p = 1.054e-18; haplotype association: log10BF = 20.925, p = 2.065e-24). These genes may affect the risk of drug addiction via modulation of the neuroimmune system. The single-SNP test exclusively reported genome-wide significant associations between rs3782886 (SNP association: log10BF = 8.726, p = 4.842e-11) in BRAP and rs671 (SNP association: log10BF = 7.406, p = 9.333e-10) in ALDH2 and drug addiction. The haplotype test exclusively reported a genome-wide significant association (haplotype association: log10BF = 7.607, p = 3.342e-11) between a region with allelic heterogeneity on chromosome 22 and drug addiction, which may be involved in the pathway of vitamin B12 transport and metabolism, indicating a causal link between lower vitamin B12 levels and methamphetamine addiction.
Conclusions
These findings provide new insights into risk-modeling and the prevention and treatment of methamphetamine and heroin dependence, which may further contribute to potential novel therapeutic approaches.
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Wang W, Lu S, Tang H, Wang B, Sun C, Zheng P, et al. A Scoping Review of Drug Epidemic Models. Int J Environ Res Public Health. 2022;19(4)
2. Ahmad FB, Cisewski JA, Rossen L, Sutton P. Vital statistics rapid release. Provisional drug overdose death counts. Maryland: National Center for Health Statistics; 2023.
3. Ahmed M. Ul Haq I, Faisal M, Waseem D, Taqi MM: implication of OPRM1 A118G polymorphism in opioids addicts in Pakistan: in vitro and in silico analysis. J Mol Neurosci. 2018;65:472–9.
4. Muller AE, Skurtveit S, Clausen T. Many correlates of poor quality of life among substance users entering treatment are not addiction-specific. Health Qual Life Outcomes. 2016;14:1–10.
5. Yuan X, Li X, Kang Y, Pang L, Hei G, Zhang X, et al. Gut mycobiota dysbiosis in drug-naive, first-episode schizophrenia. Schizophr Res. 2022;250:76–86.